Novavax Stock Climbs Monday: What's Going On?
Shares of Novavax are trading higher Monday, extending its 30% monthly gains on COVID-19 vaccine approvals and broader biotech strength.
Novavax's stock price went up because people are excited about its COVID vaccine getting approved and the whole vaccine industry is doing well. When a company gets approval for a new medicine, it often means the market thinks it could make more money soon.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.